Medication‐induced mood disorders following epidural steroid injections in patients with pain: A case series

Medication‐induced mood disorders following epidural steroid injections in patients with pain: A case series

Key Clinical Message Medication‐induced mood disorders following epidural steroid injections are possible therefore should be disclosed to the patient. Medication‐induced mood disorders have been rarely reported following epidural steroid injections (ESI). This case series presents three patients wh...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports Vol. 11; no. 6; pp. e7415 - n/a
Main Authors: Vangeison, Christian T., Roys, Joseph P., Catalanotto, Marissa N., Kupperman, Wyatt I., Kovacs, Alexander R., Dîrzu, Dan Sebastian, Husu, Emanuel N.
Format: Journal Article
Language:English
Published: England John Wiley & Sons, Inc 01-06-2023
John Wiley and Sons Inc
Wiley
Subjects:
Anxiety
Back pain
Case Report
Case reports
Delirium
Drug dosages
Emotional disorders
Endocrinology
Epidural
epidural steroid injection induced mood disorder
Insomnia
Magnetic resonance imaging
Medical referrals
medication‐induced mood disorder
Mental depression
Mental disorders
Mood disorders
Pain management
Patients
Primary care
Psychiatrists
Steroids
substance‐induced mood disorder
Suicidal behavior
medication‐induced mood disorder
case report
epidural steroid injection induced mood disorder
substance‐induced mood disorder
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Key Clinical Message Medication‐induced mood disorders following epidural steroid injections are possible therefore should be disclosed to the patient. Medication‐induced mood disorders have been rarely reported following epidural steroid injections (ESI). This case series presents three patients who met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5) criteria for substance/medication‐induced mood disorder after an ESI. In considering a candidacy for ESI, the rare but significant, side effects of psychiatric side effects should be disclosed to patients.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Report-1
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.7415